All Infection Prevention & Control articles – Page 2
-
NewsResearchers discover highly potent compound that blocks Ebola virus entry
A research team has discovered a highly potent small molecule that blocks Ebola virus entry by stabilizing the virus’s entry protein and provides strong protection when given orally in a preclinical model. It is more than 100 times more potent than previously reported Ebola entry inhibitors.
-
NewsC. diff coordinates threat response to survive in gut
Researchers have discovered a unique system C. diff uses to simultaneously sense and respond to two different threats: host-mediated nutrient deprivation and a microbiota-produced antibiotic compound, suggesting new therapeutic options for preventing and treating C. diff infections.
-
NewsEngineering bacterial surfaces with glucan nanofilms creates a potent vaccine platform against invasive fungal infections
A research team has developed a synthetic bacterium-based vaccine platform that uses engineered bacterial surfaces to assemble glucan nanofilms for enhanced antifungal immunity against pathogens such as Candida albicans.
-
NewsA pan-sRNome analysis identifies novel regulatory small RNAs involved in Pseudomonas aeruginosa virulence
A characterization of nine newly discovered sRNAs reveals their regulatory networks in quorum sensing, biofilm formation, and interbacterial competition in Pseudomonas aeruginosa.
-
NewsExpert consensus outlines 12 recommendations to prevent secondary mucormycosis after respiratory viral infections
The recommendations focus on defined high-risk patients, early viral testing and treatment, hospital infection control, and practical measures for resource-limited settings.
-
NewsNew research offers avenue to explore relationship between Alzheimer’s and HIV
Researchers have created an animal model that helps resolve questions about the relationship between HIV and Alzheimer’s disease (AD). The virus that drives the root cause of AD initiates a complex chain that, with other disease partners, drives nerve cell injury and cognitive impairments for AD pathology.
-
NewsSymposium commemorating the 50th anniversary of the discovery of the Hantaan virus successfully held
A symposium commemorating the 50th anniversary of the discovery of the Hantaan virus celebrated the historical achievement of the late Dr. Lee Ho-wang and reviewed the historical significance of Hantaan virus research, its results, and future infectious disease response strategies.
-
-
NewsHelicobacter pylori exposure may be linked to more than 1 in 5 bowel cancer cases worldwide
Exposure to the stomach microbe Helicobacter pylori may be associated with more than 1 in 5 cases of bowel cancer worldwide, suggests an exploratory risk attribution study - and those born in more recent decades may be more at risk of the disease after exposure.
-
NewsVaccine protects against multiple fungal infections without hurting the gut
A vaccine created to battle multiple life-threatening fungal infections is successful in achieving protective immunity in pre-clinical animal models while also maintaining the biodiversity of the gut microbiome, according to a new study.
-
NewsFaster diagnostics, deeper insights: Researchers strengthen response to Ebola outbreaks
Two studies provide important insights into the challenges of responding to outbreaks - one demonstrates how diagnostic tests can be evaluated rapidly during an outbreak; the other investigates the biological properties of the 2026 BDBV strain and whether an existing Ebola vaccine could offer cross-protection.
-
NewsCommonly used cancer drugs boost MRSA antibiotics – new research
Scientists tested five anti-cancer drugs and revealed that four of them helped penicillin-type antibiotics to kill MRSA. These drugs interfere with the bacteria’s ability to make DNA, making the bacteria more vulnerable to the antibiotics.
-
NewsResearch explores why strep throat can linger, even after treatment with antibiotics
Streptococcal sore throat can linger even after treatment, turning otherwise healthy children into carriers. Using whole genome sequencing, researchers hope to discover why.
-
NewsMpox outbreak in 2022 caused by less severe form of the virus
The strain of Mpox behind the 2022 outbreak was a weakened form of the virus, which may have helped to spread it faster, a new study reports. The findings show that the virus acquired mutations before it spread globally.
-
NewsShould adults with autoimmune rheumatic conditions receive updated COVID-19 vaccines?
Adults with autoimmune rheumatic conditions who developed COVID-19 and received booster or updated (2023-2024) COVID-19 vaccines were less likely to be hospitalized for COVID-19 compared to those who received only the initial series vaccines or who were unvaccinated.
-
NewsHigh-dose flu vaccine beneficial for older people with lung disease
The risk of being hospitalised for flu or pneumonia can be reduced with a high-dose flu vaccine for older people with chronic lung disease, according to the combined results of two large clinical trials.
-
NewsMember Q&A: Harta Wedari on how AMI has opened up new opportunities and communities
Dr Ni Luh Putu Harta Wedari, a medical doctor and Clinical Microbiology Specialist from Bali, Indonesia reveals how engaging with AMI has expanded her international network and unveiled new opportunities.
-
NewsKazakh researchers ID antiviral and anti-inflammatory compounds in native medicinal plants
Researchers have identified biologically active compounds with antiviral, antimicrobial, and anti-inflammatory effects in several plant species native to Kazakhstan, providing new chemical and experimental data on medicinal flora from Central Asia.
-
NewsCurious by Nature: Professor Romain Glèlè Kakaï – Can we predict the next epidemic?
Professor Romain Glèlè Kakaï believes combining traditional mathematical models with artificial intelligence will improve the accuracy of epidemic forecasting and help public health leaders respond more quickly to future cholera and malaria outbreaks.
-
NewsA fourth T6SS in clinical Pseudomonas aeruginosa deploys the pore-forming effector TseMt
The hospital-associated pathogen Pseudomonas aeruginosa has type VI secretion systems (T6SSs). Most reference strains encode three T6SSs, but comparative genomics has identified an additional H4-T6SS in a subset of clinical isolates.